文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

ARDS二十年趋势:美国全国住院患者样本分析

Secular Trends in ARDS: A 20-Year Analysis of the National Inpatient Sample.
PubMed 文献 · Chest · 2026-03-26
一句话结论2000至2019年美国机械通气ARDS患者住院死亡率在ICD-9-CM编码期逐年下降(OR 0.96/年),但ICD-10-CM编码期反而上升(OR 1.05/年),可能反映编码与病例组合变化而非真实疗效恶化。

该回顾性队列研究利用美国全国住院患者样本(NIS)2000至2019年数据,纳入205,393例成人非择期、诊断ARDS并接受有创机械通气的住院患者,按ICD-9-CM(2000年至2015年第3季度)与ICD-10-CM(2015年第4季度至2019年)两个编码期分层分析。结果显示ICD-9-CM期住院死亡率逐年下降(OR 0.96/年,95%CI 0.95-0.97,P<.001),而ICD-10-CM期住院死亡率逐年上升(OR 1.05/年,95%CI 1.01-1.08,P=.004);住院时长和住院费用在ICD-9-CM期下降,在ICD-10-CM期无显著改善。ICD-10-CM队列合并症负担更重、ARDS肺部病因比例更高。作者认为ICD-10-CM期死亡率趋势变化可能是编码与更严重病例组合的假象,强调需要一致的病例定义和识别以标准化诊疗。

要点

  • 2000至2019年205,393例机械通气ARDS住院患者中,ICD-9-CM期住院死亡率逐年下降(OR 0.96/年,95%CI 0.95-0.97,P<.001)。
  • ICD-10-CM期住院死亡率转为逐年上升(OR 1.05/年,95%CI 1.01-1.08,P=.004),住院时长与费用无显著改善。
  • ICD-10-CM队列合并症负担更重、ARDS肺部病因比例更高,作者认为死亡率趋势变化可能是编码与更严重病例组合的假象。
  • 作者强调需要一致的病例定义和识别来标准化ARDS诊疗,并指出ARDS负担持续存在。

适用人群与场景

  • 2000至2019年美国全国住院患者样本中成人、非择期住院、诊断为ARDS并同时接受有创机械通气的患者。
  • 按编码期分层:ICD-9-CM期为2000年至2015年第3季度;ICD-10-CM期为2015年第4季度至2019年。

研究设计与关键结果

  • 研究类型为回顾性队列研究,使用美国全国住院患者样本2000至2019年数据,共纳入205,393例机械通气ARDS住院患者(ICD-9-CM期n=146,888;ICD-10-CM期n=58,505)。
  • 主要结局住院死亡率:ICD-9-CM期逐年下降(OR 0.96/年,95%CI 0.95-0.97,P<.001);ICD-10-CM期逐年上升(OR 1.05/年,95%CI 1.01-1.08,P=.004)。
  • 住院时长和住院费用在ICD-9-CM期下降,在ICD-10-CM期无显著改善,作者认为可能反映ICD-10-CM期管理更复杂ARDS患者成本上升。
  • ICD-10-CM队列合并症负担更重,且更可能有ARDS的肺部病因。

证据类型、等级与局限

  • 证据类型:回顾性队列研究(使用美国全国住院患者样本数据库)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为ICD-10-CM期死亡率趋势变化可能是编码与更严重病例组合的假象,解读ARDS结局趋势时需考虑编码版本与病例组合差异。
  • 作者强调需要一致的病例定义和识别以标准化ARDS诊疗。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Mortality from ARDS remains high, but large-scale longitudinal analyses in the pre-COVID-19 era are limited.

RESEARCH QUESTION: How has in-hospital mortality changed over time among patients with mechanically ventilated ARDS in the US between 2000 and 2019?

STUDY DESIGN AND METHODS: We performed a retrospective cohort study using the National Inpatient Sample from 2000 to 2019. Adult, nonelective admissions with a diagnosis of ARDS and concurrent invasive mechanical ventilation were included. The cohort was stratified by International Classification of Diseases coding era (International Classification of Diseases Ninth Revision, Clinical Modification [ICD-9-CM]: 2000 to quarter 3, 2015; International Classification of Diseases 10th Revision, Clinical Modification [ICD-10-CM]: quarter 4, 2015 to 2019). Outcomes included in-hospital mortality, length of stay, and hospitalization charges. Hospitalization charges were adjusted for Consumer Price Index for hospital services to 2019 dollars. Adjusted trend analyses were performed separately for each coding era using logistic and linear regression models.

RESULTS: Among 205,393 mechanically ventilated ARDS admissions (ICD-9-CM: n = 146,888; ICD-10-CM: n = 58,505), mortality declined during the ICD-9-CM period (OR, 0.96 per year; 95% CI, 0.95-0.97; P < .001) but increased during the ICD-10-CM period (OR, 1.05 per year; 95% CI, 1.01-1.08; P = .004). The LOS and hospitalization charges decreased during the ICD-9-CM era but showed no significant improvement in the ICD-10-CM period, likely reflecting the rising cost of managing patients with more complex ARDS during the ICD-10-CM period. The ICD-10-CM cohort had a greater comorbidity burden and were more likely to have a pulmonary etiology for ARDS.

INTERPRETATION: This 20-year analysis reveals diverging trends in ARDS outcomes across coding eras. Improvements in mortality during the ICD-9-CM era were not sustained in the ICD-10-CM period. The apparent changes in mortality trend during the ICD-10-CM period are likely artifacts of coding and more severe case-mix. These findings underscore the ongoing burden of ARDS and highlight the need for consistent case definitions and identification to standardize care delivery.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Padappayil RP, Shah D, Jackson T, et al. Secular Trends in ARDS: A 20-Year Analysis of the National Inpatient Sample. Chest. 2026. PMID: 41903837. doi:10.1016/j.chest.2026.03.013

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。